Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods

Trial Profile

An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 May 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary) ; Ethinylestradiol/etonogestrel (Primary) ; Ethinylestradiol/levonorgestrel (Primary) ; Norethisterone enantate (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms UChoose
  • Most Recent Events

    • 02 Nov 2019 Results published in the Clinical Infectious Diseases
    • 21 Jul 2017 Planned End Date changed from 1 Feb 2016 to 1 Feb 2018.
    • 21 Jul 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2017.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top